Cart
sales@molnova.com
CBHcy
CAS No. 88096-02-0
CBHcy( —— )
Catalog No. M34057 CAS No. 88096-02-0
CBHcy is a dual-substrate analogue, a specific BHMT inhibitor that causes betaine-homocysteine S-methyltransferase (BHMT) to adopt the same conformation as the ternary complex, potentially inducing the development of cysteinemia.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 424 | Get Quote |
|
| 5MG | 658 | Get Quote |
|
| 10MG | 939 | Get Quote |
|
| 25MG | 1343 | Get Quote |
|
| 50MG | 1822 | Get Quote |
|
| 100MG | 2403 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCBHcy
-
NoteResearch use only, not for human use.
-
Brief DescriptionCBHcy is a dual-substrate analogue, a specific BHMT inhibitor that causes betaine-homocysteine S-methyltransferase (BHMT) to adopt the same conformation as the ternary complex, potentially inducing the development of cysteinemia.
-
DescriptionCBHcy is a dual-substrate analogue, a specific BHMT inhibitor that causes betaine-homocysteine S-methyltransferase (BHMT) to adopt the same conformation as the ternary complex, potentially inducing the development of cysteinemia.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetTransferase
-
RecptorTransferase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number88096-02-0
-
Formula Weight235.3
-
Molecular FormulaC9H17NO4S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(O)CCCCSCCC(N)C(=O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Nizubaglustat
Nizubaglustat (AZ3102) is an orally available, selective and brain-permeable dual inhibitor of ceramide glucosyltransferase and non-lysosomal glucosylceramide amidase (NLGase) for the study of neurological diseases.
-
SB 271046 hydrochlor...
SB 271046 hydrochloride is selective, orally active 5-HT6 antagonist.
-
AMP-Deoxynojirimycin
AMP-Deoxynojirimycin (AMP-DNM) is a potent inhibitor of ceramide glucosyltransferase and GCase 2, as well as GlcCer biosynthesis, and is utilized in the study of Parkinson's disease and diabetes.
